Long-term persistence of second-line biologics in psoriatic arthritis patients with prior TNF inhibitor exposure: a nationwide cohort study from the French health insurance database (SNDS)
Pina Vegas L, Hoisnard L, Bastard L, Sbidian E, Claudepierre P.
RMD Open. 2022 Dec;8(2):e002681.
doi: 10.1136/rmdopen-2022-002681. PMID: 36597983 Free PMC article.